ARCANA INSTITUTE

A CERTARA COMPANY

Arcana Institute (INAR) is now part of Certara, a global leader in model-informed drug development and regulatory science.

Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides support for drug development through the product’s full life cycle, from clinical trial planning & design, drug registration, Real World Data, strategic support in HEOR and Market Access, up to reimbursement and beyond.

Certara’s staff includes over 700 experts in more than 20 offices worldwide!

Together, we are creating innovative analytical methods to provide our partners with the highest-quality scientific evidence in safety, clinical efficacy and effectiveness for medical technologies.

find out more

Business Partners

Cooperative Institutions

News

28 November 2019

Analysis of the Reimbursement Decision-Making Practice in Poland (November 2019)

The results include the notice of the Minister of Health of 23 October 2019, effective 1st of November 2019. We track the Minister of Health’s reimbursement decisions and AHTAPol’s  more...
2 September 2019

Analysis of the Reimbursement Decision-Making Practice in Poland (September 2019)

The results include the notice of the Minister of Health from 30 August 2019, effective 1st of September 2019. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements  more...
7 August 2019

VII HTA Krakow Symposium 2019

Arcana Institute hosted its annual HTA Symposium in Krakow, bringing together recognized experts from the public and private sectors to discuss current events and challenges taking place in Poland  more...